Four predictions for the smart money in 2024
As any casual reader here will surmise, Union Healthcare Insight neither provides investment recommendations, nor endorses companies, providers, or anyone else. So, in talking about “where the smart money is going in 2024” I’m in no way suggesting that if you are smart, you’ll imitate the trends I’m describing.
At a glance
Read on to get our full commentary, or use the links below to jump to a specific area of interest:
As any casual reader here will surmise, Union Healthcare Insight neither provides investment recommendations, nor endorses companies, providers, or anyone else. So, in talking about “where the smart money is going in 2024” I’m in no way suggesting that if you are smart, you’ll imitate the trends I’m describing. Instead, my focus in today’s post is on analyzing institutional investment, i.e., where financial services or other major healthcare investors are placing their bets—in particular Wall Street, private equity, venture capital—plus the big insurers, drugmakers, and providers.
Why? Because it’s always a good idea to know where the markets are betting big. What do they see for this year and the next several that may not be as clear to the casual observer?
Based on our recent interviews with investors, attendance at healthcare investment conferences and retreats, and scouring the financial literature, here is our take—starting with a fast recap of the recent past, followed by four predictions for the rest of 2024.
Union Healthcare Insight
Log in to continue reading
Not a member yet? Create a free account for limited access.
Related insights
The new patient financial reality
The Great Utilization Shift
How one health system is creatively pushing back against a labor squeeze